|
|
Blood, 1 March 2006, Vol. 107, No. 5, pp. 1888-1891.
Prepublished online as a Blood First Edition Paper on October 27, 2005; DOI 10.1182/blood-2005-06-2304.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Brief report
AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation
Saghi Ghaffari,
Claire Kitidis,
Wei Zhao,
Dragan Marinkovic,
Mark D. Fleming,
Biao Luo,
Joseph Marszalek, and
Harvey F. Lodish
From the Department of Gene and Cell Medicine, Brookdale Department of Molecular, Cell, and Developmental Biology, the Department of Medicine, Division of Hematology, Oncology, and the Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, NY; Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Pathology, Children's Hospital, Harvard Medical School, Boston, MA; and Department of Biology, Massachusetts Institute of Technology, Cambridge.
AKT serine threonine kinase of the protein kinase B (PKB) family plays essential roles in cell survival, growth, metabolism, and differentiation. In the erythroid system, AKT is known to be rapidly phosphorylated and activated in response to erythropoietin (Epo) engagement of Epo receptor (EpoR) and to sustain survival signals in cultured erythroid cells. Here we demonstrate that activated AKT complements EpoR signaling and supports erythroid-cell differentiation in wild-type and JAK2-deficient fetal liver cells. We show that erythroid maturation of AKT-transduced cells is not solely dependent on AKT-induced cell survival or proliferation signals, suggesting that AKT transduces also a differentiation-specific signal downstream of EpoR in erythroid cells. Down-regulation of expression of AKT kinase by RNA interference, or AKT activity by expression of dominant negative forms, inhibits significantly fetal liver–derived erythroid-cell colony formation and gene expression, demonstrating that AKT is required for Epo regulation of erythroid-cell maturation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression
- Stuart T. Fraser, Joan Isern, and Margaret H. Baron
Blood 2007 109: 343-352.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
P. Sathyanarayana, A. Dev, J. Fang, E. Houde, O. Bogacheva, O. Bogachev, M. Menon, S. Browne, A. Pradeep, C. Emerson, et al.
EPO receptor circuits for primary erythroblast survival
Blood,
June 1, 2008;
111(11):
5390 - 5399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Grebien, M. A. Kerenyi, B. Kovacic, T. Kolbe, V. Becker, H. Dolznig, K. Pfeffer, U. Klingmuller, M. Muller, H. Beug, et al.
Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2
Blood,
May 1, 2008;
111(9):
4511 - 4522.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Fang, M. Menon, W. Kapelle, O. Bogacheva, O. Bogachev, E. Houde, S. Browne, P. Sathyanarayana, and D. M. Wojchowski
EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts
Blood,
October 1, 2007;
110(7):
2361 - 2370.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Sathyanarayana, M. P. Menon, O. Bogacheva, O. Bogachev, K. Niss, W. S. Kapelle, E. Houde, J. Fang, and D. M. Wojchowski
Erythropoietin modulation of podocalyxin and a proposed erythroblast niche
Blood,
July 15, 2007;
110(2):
509 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. K. Bone and M. J. Welham
Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis
J. Cell Sci.,
May 15, 2007;
120(10):
1752 - 1762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Rimmele, O. Kosmider, P. Mayeux, F. Moreau-Gachelin, and C. Guillouf
Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation
Blood,
April 1, 2007;
109(7):
3007 - 3014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. T. Fraser, J. Isern, and M. H. Baron
Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression
Blood,
January 1, 2007;
109(1):
343 - 352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. G.P. Bumm, C. Elsea, A. S. Corbin, M. Loriaux, D. Sherbenou, L. Wood, J. Deininger, R. T. Silver, B. J. Druker, and M. W.N. Deininger
Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Cancer Res.,
December 1, 2006;
66(23):
11156 - 11165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Garcon, C. Rivat, C. James, C. Lacout, V. Camara-Clayette, V. Ugo, Y. Lecluse, A. Bennaceur-Griscelli, and W. Vainchenker
Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells
Blood,
September 1, 2006;
108(5):
1551 - 1554.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Blobel
GATA-1 caught in the AKT
Blood,
February 1, 2006;
107(3):
851a - 852.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Zhao, C. Kitidis, M. D. Fleming, H. F. Lodish, and S. Ghaffari
Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway
Blood,
February 1, 2006;
107(3):
907 - 915.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
